fda warning peptides bpc-157 tb-500 peptide products unapproved BPC-157 / (Tβ4) Blend Buy BPC 157 TB 500
Description
Supplier credibility: TB-500 breaks down with light and oxygen
The overall discontinuation rate was 4.3% to 7.1% (Jastreboff et al., NEJM 2022)
The selection of appropriate bacteriostatic water prevents the possibility of contamination and dosing error during injections
The compound has never received market authorization in Canada or anywhere else, and Metabolic Pharmaceuticals terminated clinical development in 2007 after the Phase IIb obesity trial failed
